EQ · Equillium Inc
United States · RS rating 28 · As of 2026-11-03
| Price | 1.41 USD |
|---|---|
| 1-day change | +2.2% |
| RS rating (overall / 1M / 3M / 12M) | 28 / 50 / 16 / 51 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 31 / 28 / 46 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | +33.3% |
| Sales growth Q/Q | – |
| Distance from 52-week high | +55.9% |
| Market cap (USD) | $137.2M |